https://sermo.peptidesanjose.com/blogs/news 2026-08-06T12:05:16-04:00 weekly https://sermo.peptidesanjose.com/blogs/news/aod-9604-and-compounded-glp-1s-mitigating-muscle-loss 2026-07-19T23:01:41-04:00 weekly https://sermo.peptidesanjose.com/blogs/news/tirzepatide-vs-retatrutide-for-stubborn-belly-fat 2026-07-23T12:05:53-04:00 weekly https://sermo.peptidesanjose.com/blogs/news/aod-9604-vs-tirzepatide-for-lean-mass-preservation 2026-07-27T12:05:02-04:00 weekly https://sermo.peptidesanjose.com/blogs/news/tirzepatide-and-mots-c-synergy-for-metabolic-flexibility 2026-07-30T12:06:41-04:00 weekly https://sermo.peptidesanjose.com/blogs/news/can-aod-9604-be-a-safer-alternative-amid-fda-warnings-on-compounded-glp-1s 2026-08-03T12:03:59-04:00 weekly https://sermo.peptidesanjose.com/blogs/news/tirzepatide-and-aod-9604-for-alcohol-cravings-va-trial-clues 2026-08-06T12:05:16-04:00 weekly